+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2



In vitro activity of 79 antimicrobial agents against Corynebacterium group D2



Antimicrobial Agents and ChemoTherapy 35(10): 2140-2143



Corynebacterium gorup D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a umber of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. .beta.-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Deoxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007437291

Download citation: RISBibTeXText

PMID: 1759839

DOI: 10.1128/aac.35.10.2140


Related references

Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrobial Agents and ChemoTherapy 31(5): 821-822, 1987

In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae. Journal of Antimicrobial ChemoTherapy 47(1): 27-31, 2001

In vitro activity of newer antimicrobial agents against multi-drug resistant Corynebacterium urealyticum. International Journal of Antimicrobial Agents 19(Suppl. 1): S31-S32, 2002

In Vitro Activity of 22 Antimicrobial Agents against Corynebacterium and Microbacterium Species Referred to the Canadian National Microbiology Laboratory. Clinical Microbiology Newsletter 37(23): 187-198, 2015

In vitro activity of various new antimicrobial agents against group JK corynebacteria. European Journal of Clinical Microbiology 6(4): 491-492, 1987

Corynebacterium pseudotuberculosis: in vitro susceptibility to 39 antimicrobial agents. Veterinary Microbiology 27(2): 145-150, 1991

Comparative in vitro activity of PD 131628 and other antimicrobial agents against the Bacteroides fragilis group. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 146, 1995

In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). Journal of Antimicrobial Chemotherapy 37(5): 1005-1009, 1996

Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Diagnostic Microbiology and Infectious Disease 34(2): 123-134, 1999

Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents. Antimicrobial Agents and ChemoTherapy 18(6): 976-977, 1980

In vitro activity of 14 antimicrobial agents against clindamycin resistant bacteroides fragilis group strains. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 233, 1992

In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents. ChemoTherapy 33(1): 28-39, 1987

Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group. Diagnostic Microbiology and Infectious Disease 30(2): 113-119, 1998

In vitro susceptibility of equine-obtained isolates of Corynebacterium pseudotuberculosis to gallium maltolate and 20 other antimicrobial agents. Journal of Clinical Microbiology 52(7): 2684-2685, 2014

In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrobial Agents and ChemoTherapy 35(10): 1960-1964, 1991